Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Innovation Pharmaceuticals IPIX
Posted On: 08/22/2016 7:16:04 PM
Post# of 72447
Avatar
Posted By: sox0407
Re: Loose Lips #26641
Based on recent deals, an effective cancer drug against one solid tumor type is worth about $5B-10B. We all know how much Imbruvica was sold for. Kevetrin has the potential to treat both solid and blood cancers. That's why I was disappointed when the AML trial was put on hold due to lack of funding.

I agree that if the K-OC trial is successful, CTIX should have no problem finding partners for other indications.

Quote:
Likely it will get to market for ovarian cancer first, but when CTIX secures a partnership and funding from the other drugs, they may be able to open up several other pathways for K in parallel with the ovarian cancer indication.














(0)
(0)






Dont-give-up.jpg



  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site